HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cosmeceuticals not slowing

This article was originally published in The Rose Sheet

Executive Summary

While the general cosmetics market is likely to be down about 1.2% in 2009, cosmeceutical sales are expected to grow 7.7% for the year and break $4 bil. by 2011, "driven by America's obsession with anti-aging and wellness" and products' perceived health advantages based on consumer assumption that the ingredients are "expensive and uniquely manufactured," research firm IBISWorld says Oct. 6. In reality, administrative and marketing costs represent more than 20% of the expense associated with cosmeceuticals, versus 2% for R&D, firm says. "Because the profit margins are higher on cosmeceuticals, companies have more money to spend on marketing," says Senior Analyst Toon van Beeck. "Businesses must continually convince buyers of the product's benefits and break through competitive clutter to increase their sales." Even beyond 2011, the cosmeceutical segment will continue to grow in near double digits, IBISWorld predicts. Currently the market is valued at $3.5 bil
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS016465

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel